<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02665663</url>
  </required_header>
  <id_info>
    <org_study_id>2015-18</org_study_id>
    <nct_id>NCT02665663</nct_id>
  </id_info>
  <brief_title>Tongue Strength in Amyotrophic Lateral Sclerosis (ALS)</brief_title>
  <official_title>Measure of the Strength of the Tongue in Patients With Amyotrophic Lateral Sclerosis and Relation With Swallowing Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease with a poor prognosis that
      occurs in adults 64 years on average. Its prevalence is 4 to 6/100 000 inhabitants.

      Swallowing disorders occur during evolution and involve the prognosis of patients in the
      short term by the association of dysphagia with severe malnutrition, and aspiration. The
      issue of phoniatric monitoring is to detect early onset of the swallowing disorders to
      develop strategies for respiratory protection, food adapted to disturbances, and speech
      therapy.

      The objective of this study is to compare the tongue force in patients with amyotrophic
      lateral sclerosis at the time of diagnosis and at the onset of swallowing disorders compared
      to healthy subjects, with the dynamic palatography device developed in the Laboratoire Parole
      et Langage (UMR 7309, CNRS-Université Aix-Marseille, Aix-en-Provence), which allows the
      measurement of the strength and duration of the pression of the tongue on the palate.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Maximum tongue strength</measure>
    <time_frame>30 minutes</time_frame>
    <description>maximal tongue strength during salivary swallowing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tongue contact duration</measure>
    <time_frame>30 minutes</time_frame>
    <description>Duration of tongue and palate contact during salivary</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Amyotrophic Lateral Sclerosis</condition>
  <arm_group>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Constitution of a control group consisting of 20 healthy volunteers, matched for age and sex to establish a &quot;normal&quot; pressure force of the language depending on the age and sex value</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with Amyotrophic Lateral Sclerosis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Constitution of a group of 20 patients with Amyotrophic Lateral Sclerosis (ALS), included at diagnosis of the disease on clinical and electromyographic arguments addressed in speech pathology consultation without a complaint swallowing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients with Amyotrophic Lateral Sclerosis and swallowi</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Constitution of a group of 20 patients with Amyotrophic Lateral Sclerosis ( ALS) and swallowing disorders clinically objectified in the ENT consultation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>medical device</intervention_name>
    <arm_group_label>healthy volunteers</arm_group_label>
    <arm_group_label>Patients with Amyotrophic Lateral Sclerosis</arm_group_label>
    <arm_group_label>patients with Amyotrophic Lateral Sclerosis and swallowi</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults and legally responsible/ valid medical insurance

          -  patients : ALS diagnostic already announced

          -  healthy subjects : EAT-10 score&lt;2

        Exclusion Criteria:

          -  Non pregnant and non baby feeding

          -  Presence of risk factor or suspicion of Creutzfeld Jacob Disease

          -  Allergy/intolerance to the glueing paste

          -  Antecedent of pathology of the aerodigestive tract

          -  Other neurologic disease

          -  Morphologic anomaly of the aerodigestive tract

          -  Excessive gag reflex
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Urielle DESALBRES</last_name>
    <role>Study Director</role>
    <affiliation>Assistance Publique Hôpitaux de Marseille</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aude LAGIER, MCU-PH</last_name>
    <phone>04 91 38 60 71</phone>
    <email>aude.lagier@ap-hm.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service ORL Assistance Publique Hôpitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aude LAGIER, MCU-PH</last_name>
      <phone>04 91 38 60 71</phone>
      <email>aude.lagier@ap-hm.fr</email>
    </contact>
    <investigator>
      <last_name>Aude LAGIER, MCU-PH</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 25, 2016</study_first_submitted>
  <study_first_submitted_qc>January 27, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 28, 2016</study_first_posted>
  <last_update_submitted>January 27, 2016</last_update_submitted>
  <last_update_submitted_qc>January 27, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

